{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:55:56Z","timestamp":1770224156310,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korean government","award":["No. 2019M3E5D1A02069616"],"award-info":[{"award-number":["No. 2019M3E5D1A02069616"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We report a case of Meige\u2019s syndrome induced by an atypical antipsychotic (blonanserin) that presented with refractory dry eye disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 37-year-old woman with a 6-month history of foreign body sensation in the eyes and difficulty in opening her eyes was treated at a local clinic for dry eye disease. Despite this treatment, her symptoms did not improve and she was transferred to our attention. Our assessment revealed involuntary movements of her eyelids accompanied by repetitive pursing of her lips. She had been undergoing treatment with blonanserin for 5\u00a0years for schizophrenia. She was diagnosed with drug-induced Meige\u2019s syndrome after a psychiatric and neurological consultation. After a 2-month gradual dose reduction and discontinuing blonanserin, involuntary movements of the eyelids with oromandibular dystonia were resolved. Three months after discontinuing blonanserin, there was no recurrence of symptoms, and she had no exacerbation of psychotic symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In patients with refractory dry eye disease, especially those with involuntary movements of the eyelids with oromandibular dystonia, it is important to ask about their psychotropic medications and to consider the possibility of drug-induced Meige\u2019s syndrome and discontinuation of medications, if possible.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-020-01738-w","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T12:03:16Z","timestamp":1606910596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Refractory dry eye disease associated with Meige\u2019s syndrome induced by long-term use of an atypical antipsychotic"],"prefix":"10.1186","volume":"20","author":[{"given":"Ji Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"key":"1738_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/bjo.81.6.439","volume":"81","author":"K Tsubota","year":"1997","unstructured":"Tsubota K, Fujihara T, Kaido M, Mori A, Mimura M, Kato M. Dry eye and Meige\u2019s syndrome. Br J Ophthalmol. 1997;81:439\u201342.","journal-title":"Br J Ophthalmol"},{"key":"1738_CR2","unstructured":"Meige\u2019s H. Les convulsion de la face, une forme clinique de convulsion faciale, bilateral et mediane. Rev Neurol (Paris). 1910;10:437\u201343."},{"key":"1738_CR3","first-page":"1","volume":"80","author":"N Poungvarin","year":"1997","unstructured":"Poungvarin N, Devahastin V, Chaisevikul R, Prayoonwiwat N, Viriyavejakul A. Botulinum a toxin treatment for blepharospasm and Meige\u2019s syndrome: report of 100 patients. J Med Assoc Thai. 1997;80:1\u20138.","journal-title":"J Med Assoc Thai"},{"key":"1738_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jns.2016.11.053","volume":"372","author":"S Pandey","year":"2017","unstructured":"Pandey S, Sharma S. Meige\u2019s syndrome: history, epidemiology, clinical features, pathogenesis and treatment. J Neurol Sci. 2017;372:162\u201370.","journal-title":"J Neurol Sci"},{"key":"1738_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","author":"MA Lemp","year":"2007","unstructured":"Lemp MA, Baudouin C, Baum J, Dogru M, Foulks GN, Kinoshita S, et al. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75\u201392.","journal-title":"Ocul Surf"},{"issue":"Suppl 11","key":"1738_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ophtha.2017.07.022","volume":"124","author":"P Thulasi","year":"2017","unstructured":"Thulasi P, Djalilian A. Update in current diagnostics and therapeutics of dry eye disease. Ophthalmology. 2017;124(Suppl 11):27\u201333.","journal-title":"Ophthalmology"},{"key":"1738_CR7","first-page":"222","volume":"28","author":"S Zhao","year":"2016","unstructured":"Zhao S, Zhang Y, Xu L, Wei L, Chen W. A case report of psychoactive drugs aggravating and alleviating Meige\u2019s Syndrome. Shanghai Arch Psychiatry. 2016;28:222\u20136.","journal-title":"Shanghai Arch Psychiatry"},{"key":"1738_CR8","first-page":"445","volume":"52","author":"T Hayashi","year":"1998","unstructured":"Hayashi T, Furutani M, Taniyama J, Kiyasu M, Hikasa S, Horiguchi J, et al. Neuroleptic-induced Meige\u2019s syndrome following akathisia: pharmacologic characteristics. PsychiClinNeurosci. 1998;52:445\u20138.","journal-title":"PsychiClinNeurosci"},{"key":"1738_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.pnpbp.2010.09.005","volume":"35","author":"W Umene-Nakano","year":"2011","unstructured":"Umene-Nakano W, Yoshimura R, Hori H, Okamoto T, Nakamura J. A case of schizophrenia with Meige syndrome induced by long-term aripiprazole successfully treated with perospirone. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:273.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1738_CR10","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1176\/appi.neuropsych.12020029","volume":"25","author":"S Takahashi","year":"2013","unstructured":"Takahashi S, Suzuki M, Uchiyama M. A case of schizophrenia with meige syndrome induced by perospirone successfully treated with biperiden. J Neuropsychiatry Clin Neurosci. 2013;25:E28.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1738_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5152\/npa.2015.7411","volume":"52","author":"A Kili\u00e7","year":"2015","unstructured":"Kili\u00e7 A, Erten E, \u00d6zdemir A. Tardive blepharospasm and Meige syndrome during treatment with Quetiapine and Olanzapine. Arch Neuropsychiat. 2015;52:207\u20139.","journal-title":"Arch Neuropsychiat"},{"key":"1738_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7888\/juoeh.38.233","volume":"38","author":"R Yoshimura","year":"2016","unstructured":"Yoshimura R, Hori H, Katsuki A, Atake K. Marked Improvement of Meige syndrome in a Japanese male patient with schizophrenia after switching from risperidone to paliperidone: a case report. J UOEH. 2016;38:233\u20136.","journal-title":"J UOEH"},{"key":"1738_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4088\/PCC.16l01997","volume":"19","author":"JG Marques","year":"2017","unstructured":"Marques JG. Oral facial dystonia (meige or brueghel syndrome) induced by paliperidonepalmitate. Prim Care Companion CNS Disord. 2017;19:254.","journal-title":"Prim Care Companion CNS Disord"},{"key":"1738_CR14","first-page":"77","volume-title":"Comprehensive care of schizophrenia (second edition): a textbook of clinical management","author":"S Miyamoto","year":"2012","unstructured":"Miyamoto S, Fleischhacker WW, Lieberman JA. Pharmacologic treatment of schizophrenia. In: Lieberman JA, Murray RM, editors. Comprehensive care of schizophrenia (second edition): a textbook of clinical management. New York: Oxford University Press; 2012. p. 77\u2013138."},{"key":"1738_CR15","first-page":"254","volume":"6","author":"GR Saraswathy","year":"2015","unstructured":"Saraswathy GR, Virupaksha HS, Thejaswi G, Lakshmi NA. Blonanserin induced hypokinesia and Tardive Dyskinesia. J Mol Biomark Diagn. 2015;6:254.","journal-title":"J Mol Biomark Diagn"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01738-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-020-01738-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01738-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T04:45:48Z","timestamp":1606970748000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01738-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1738"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01738-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the Institutional Review Board of Inha University Hospital, and the IRB waived the requirement for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"474"}}